Tag: CAR-T
Hope Restored: Woman triumphs over Lymphoma with CAR-T Cell Therapy
She’s the first person in Andhra Pradesh to have been successfully treated with indigenously built therapy
President of India launches country’s first home-grown gene therapy for cancer
The accessible and affordable car-t cell therapy provides a new hope for the whole of humankind: president Droupadi Murmu
Amrita Hospital ties up with ImmunoACT to introduce CAR T-cell Therapy...
This strategic partnership between Amrita Hospital, Faridabad and IIT Bombay incubated company will ensure that patients across all segments benefit from this life-saving advanced medicine
BioVoice eMagazine July 2023 | Issue 7 | Volume 4
This edition showcases the top 10 biotechnologies to watch out for in 2023. Insightful interviews of Piyush Sohani, Managing Director, Sistema.bio India and Dr Rachna Dave, CEO & Founder of MicroGO.
Growing investment in biotech startups likely to make CAR-T therapies affordable...
Increased investments likely to boost the research and production capabilities and eventually makes the therapies affordable to those in need, says GlobalData, a leading data and analytics company.
Post NHS approval, sky is the limit for Novartis’ CAR-T therapy:...
According to GlobalData forecasts, the Novartis CAR-T therapy, Kymriah is expected to hit over $1billion sales revenue by 2023 in the US alone......……….
Pricing adjustments for CAR-T therapies likely to take place in 2018,...
A fairly comprehensive study reported in February 2018 on the Health Affairs Blog claims that Novartis could lower the price of Kymriah by two-thirds and still achieve a profit..................